Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
en
nl
fr
de
Search
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
Working at Gimv
Contact
Latest news Latest news Latest news
Latest news
Filter news
Authored on
*
(Optional)
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Category
*
(Optional)
Category
Corporate
Portfolio
Investment platform
*
(Optional)
Investment platform
Consumer
Healthcare
Life Sciences
Smart Industries
Sustainable Cities
Apply
Show all
Portfolio
Spineart completes enrollment in the BAGUERA®C IDE trial for two-level cervical disc replacement
08/03/2024 - 08:39
Corporate
Share buyback finalised
29/02/2024 - 07:45
Portfolio
Sagard acquires Groupe Acceo from Gimv
27/02/2024 - 07:45
Corporate
Announcement of share buyback in the context of a share purchase plan for its personnel
21/02/2024 - 07:45
Portfolio
Fronnt further expands and strengthens its offering through the acquisition of Bovema International
06/02/2024 - 13:08
Portfolio
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
16/01/2024 - 07:30
Portfolio
AME and Variass join forces by establishing Metis Group
09/01/2024 - 16:20
Portfolio
Gimv invests in Castelein Sealants to accelerate European growth
19/12/2023 - 07:30
Portfolio
WEMAS partners with Sekisui Jushi Corporation (“SJC”) to pursue further expansion after growth journey alongside Gimv and Paragon Partners
08/12/2023 - 12:00
Corporate
Gimv welcomes WorxInvest as reference shareholder
30/11/2023 - 21:24
Corporate
Strong results confirm strategy of value creation through growth
23/11/2023 - 06:58
Portfolio
Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs, Strategic Collaborations and Key Leadership Addition
25/10/2023 - 16:52
Pagination
See more news
Do you want to stay updated about Gimv news?
Subscribe to our press releases
Contact information
Investor Relations Investor Relations Investor Relations
Investor Relations
Do you have any questions or require more information? Please contact us.
Contact us